RECURRENT NASOPHARYNGEAL KERATINIZING SQUAMOUS CELL CARCINOMA

Clinical trials for RECURRENT NASOPHARYNGEAL KERATINIZING SQUAMOUS CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT NASOPHARYNGEAL KERATINIZING SQUAMOUS CELL CARCINOMA trials appear

Sign up with your email to follow new studies for RECURRENT NASOPHARYNGEAL KERATINIZING SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Terminated 1

Scientists test new drug duo in fight against tough nasal cancers

Disease control Ongoing

This early-stage trial is testing the safety and best dose of a two-drug combination (vorinostat and azacitidine) for patients with advanced nasal and throat cancers that have returned or spread. The study aims to see if these drugs, which work differently to stop cancer cell gro…

Matched conditions: RECURRENT NASOPHARYNGEAL KERATINIZING SQUAMOUS CELL CARCINOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 17, 2026 13:09 UTC

RECURRENT NASOPHARYNGEAL KERATINIZING SQUAMOUS CELL CARCINOMA

Get alerted when new RECURRENT NASOPHARYNGEAL KERATINIZING SQUAMOUS CELL CARCINOMA trials appear

Scientists test new drug duo in fight against tough nasal cancers